Bill > S998

This bill seeks to improve the resilience of medical supply chains in the United States by authorizing the President to enter into trade agreements with trusted international partners. The legislation was largely prompted by challenges exposed during the COVID-19 pandemic, where the United States experienced significant difficulties procuring critical medical goods and discovered over-reliance on a small number of countries for imports. The bill establishes a framework for creating "trusted trade partner agreements" with countries that demonstrate commitments to global health security, intellectual property protection, and maintaining open trade during public health emergencies. Key purposes include diversifying medical supply networks, eliminating trade barriers, expediting cross-border movement of medical goods, promoting international research collaboration, and increasing manufacturing capacities for medical devices and pharmaceutical products. The bill includes extensive congressional oversight provisions, requiring the President to notify Congress before negotiations, consult with relevant committees, and submit detailed reports about potential agreements. Additionally, the legislation creates mechanisms for monitoring partner compliance and potential enforcement actions if a country fails to meet its commitments. The ultimate goal is to enhance national security and public health by creating more robust, flexible, and reliable medical supply chains that can better withstand global disruptions.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/998/all-info